Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C K Welt

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Human Reproduction (Oxford, England)|May 11, 2006
Control of estradiol secretion in reproductive ageingC K Welt, Y Jimenez, P M Sluss, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Presence of activin, inhibin, and follistatin in epithelial ovarian carcinomaC K Welt, G Lambert-Messerlian, W Zheng, et al.
Human Reproduction (Oxford, England)|May 22, 2015
Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volumeR Saxena, A C Bjonnes, N A Georgopoulos, et al.
Human Reproduction (Oxford, England)|August 26, 2023
Family size for women with primary ovarian insufficiency and their relativesL E Verrilli, K Allen-Brady, E B Johnstone, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndromeS Gill, A E Taylor, K A Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrationsA L Schneyer, T Fujiwara, J Fox, et al.
Human Reproduction (Oxford, England)|April 24, 2015
Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose toleranceR Saxena, N A Georgopoulos, T J Braaten, et al.
Neuroendocrinology|July 15, 1998
Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient modelK A Martin, C K Welt, A E Taylor, et al.
Human Reproduction (Oxford, England)|December 10, 2024
Turner syndrome: fertility, familial clustering, and cancer riskK Allen-Brady, L E Verrilli, B A Austin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 28, 2006
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic featuresC K Welt, J A Gudmundsson, G Arason, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Human Reproduction (Oxford, England)|May 11, 2006
Control of estradiol secretion in reproductive ageingC K Welt, Y Jimenez, P M Sluss, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Presence of activin, inhibin, and follistatin in epithelial ovarian carcinomaC K Welt, G Lambert-Messerlian, W Zheng, et al.
Human Reproduction (Oxford, England)|May 22, 2015
Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volumeR Saxena, A C Bjonnes, N A Georgopoulos, et al.
Human Reproduction (Oxford, England)|August 26, 2023
Family size for women with primary ovarian insufficiency and their relativesL E Verrilli, K Allen-Brady, E B Johnstone, et al.
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndromeS Gill, A E Taylor, K A Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrationsA L Schneyer, T Fujiwara, J Fox, et al.
Human Reproduction (Oxford, England)|April 24, 2015
Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose toleranceR Saxena, N A Georgopoulos, T J Braaten, et al.
Neuroendocrinology|July 15, 1998
Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient modelK A Martin, C K Welt, A E Taylor, et al.
Human Reproduction (Oxford, England)|December 10, 2024
Turner syndrome: fertility, familial clustering, and cancer riskK Allen-Brady, L E Verrilli, B A Austin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 28, 2006
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic featuresC K Welt, J A Gudmundsson, G Arason, et al.
Pageof 3